5 Result(s)
within
Eoin P. Flanagan
Biomedicine
-
Article
Open AccessClinical features and outcomes in primary nervous system histiocytic neoplasms
-
Article
Open AccessCorrection: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)
-
Article
Inpatient rehabilitation outcomes in patients with the new diagnosis of COVID-19 tractopathy: a case series
Retrospective Case Series.
-
Article
Open AccessImplementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)
In the United States, rare disease (RD) is defined as a condition that affects fewer than 200,000 individuals. Collectively, RD affects an estimated 30 million Americans. A significant portion of RD has an und...
-
Article
Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD
Aquaporin-4 (AQP4)-IgG seropositive neuromyelitis optica spectrum disorders (AQP4-IgG seropositive NMOSD) and myelin oligodendrocyte glycoprotein (MOG)–IgG-associated disease (MOGAD) are inflammatory demyelina...
